Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients

Autor:	Jeffrey A. Borgia, Zahraa Ibrahem, John C. Kubasiak, Ravi Pithadia, Sanjib Basu, Wen-Rong Lie, Cristina Fhied, Mary J. Fidler, Shruthi Melinamani, Ibdihaj Fughhi, Marta Batus, Philip Bonomi
Rok vydání:	2014
Předmět:	Oncology Cancer Research medicine.medical_specialty Radiation genetic structures Bevacizumab business.industry non-small cell lung cancer (NSCLC) medicine.disease Predictive value Internal medicine medicine Radiology Nuclear Medicine and imaging In patient business medicine.drug
Zdroj:	International Journal of Radiation Oncology*Biology*Physics. 90:S75
ISSN:	0360-3016
DOI:	10.1016/j.ijrobp.2014.08.314
Popis:	11037 Background: Trials evaluating role of bevacizumab in patients with advanced NSCLC have shown only modest impact in outcomes. The objective of this study was to evaluate predictive value of pa...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47791fbcbe750c56fc23bdcb501d598f https://doi.org/10.1016/j.ijrobp.2014.08.314 Zobrazit plný text záznamu